Key facts
- Zelis Healthcare’s last known valuation is $17.0B (Oct 2025).
- It has raised $7.0B across 1 recorded rounds; the latest was Secondary Transaction - Private ($4.3B) in Nov 2024.
- Notable investors include Mubadala Investment Company, Bain Capital Ventures, Norwest, Bain Capital, HarbourVest Partners — 10 tracked in total.
- Status: In IPO Registration.
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Zelis Healthcare
Funding rounds
1 roundsAbout Zelis Healthcare
Developer a healthcare information technology platform designed for end-to-end healthcare claims cost management and payment services. The company's technology tool offers network management, claims integrity, and electronic payments, helping healthcare payer clients, providers and consumers efficiently operate and stay current with changing regulations in the complex and evolving healthcare financial landscape.
- Industry
- Enterprise Systems (Healthcare)
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 1995
- Employees
- 2,952
- Website
- zelis.com/
- Ownership
- In IPO Registration
Zelis Healthcare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zelis Healthcare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zelis Healthcare in its N-PORT filings yet. We sweep new filings monthly.